I want to talk to you today about the Together trial on ivermectin as a treatment for Covid-19. There is a lot of discussion about the quality of the data and the conclusions drawn in this trial – but there is an equally, if not more, important point to consider.
Whenever new trial data comes along, as with the Together trial, it is essential to put it in context. That is, it must be e [...]